arrow
J

James B. Leverenz

cleveland clinic
H指数:98
被引数:4.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Alzheimer’s disease target and drug discovery by leveraging multiomics and electronic health data

阿尔茨海默病靶点与药物发现:利用多组学和电子健康数据

2026-10-080
OA
Cerebrospinal Fluid Over Plasma Links Analytes to Cognitive Decline in Older Adults at Risk for Alzheimer's Disease

脑脊液与血浆的关联性将分析物与阿尔茨海默病风险老年人群的认知衰退联系起来

2026-09-180
OAAI
Recommended approaches to sharing individual research results in Alzheimer's disease research: A multidisciplinary expert Delphi consensus

阿尔茨海默病研究中分享个体研究结果的推荐方法:一项多学科专家德尔菲共识

2025-09-250
PRE
Single-microglia transcriptomic transition network-based prediction and real-world patient data validation identifies ketorolac as a repurposable drug for Alzheimer's disease
2024-12-060
PRE
Long-Term Dementia Risk in Parkinson Disease
2024-09-100
OAAI
Association of CSF α-Synuclein Seeding Amplification Assay Results With Clinical Features of Possible and Probable Dementia With Lewy Bodies
2024-08-134
PRE
Identification of Parkinson's disease PACE subtypes and repurposing treatments through integrative analyses of multimodal data
2024-07-092
OAAI
Relationships between plasma biomarkers, tau PET, FDG PET, and volumetric MRI in mild to moderate Alzheimer's disease patients

轻度至中度阿尔茨海默病患者血浆生物标志物,tau PET,FDG PET和容积MRI之间的关系

2024-07-094
OAAI
ATN cerebrospinal fluid biomarkers in dementia with Lewy bodies: Initial results from the United States Dementia with Lewy Bodies Consortium

路易体痴呆的ATN脑脊液生物标志物: 美国路易体痴呆联盟的初步结果

2023-09-235
OA
Cleveland Clinic Cognitive Battery (C3B): Normative, Reliability, and Validation Studies of a Self-Administered Computerized Tool for Screening Cognitive Dysfunction in Primary Care

克利夫兰诊所认知电池 (C3B): 用于筛查初级保健中认知功能障碍的自我管理计算机化工具的规范,可靠性和验证研究

2023-02-202
OAAI